IP Library Granted Patent US 11,814,338
Granted Patent B2
US 11,814,338 · App. 17/457,808 · Granted Nov 14, 2023

Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

Inventors: Eric Anderson (Southlake, TX); Gary L. Bolton (Ann Arbor, MI); Bradley Caprathe (Livonia, MI); Xin Jiang (Coppell, TX); Chitase Lee (Ann Arbor, MI); William H. Roark (Ann Arbor, MI); Melean Visnick (Irving, TX)
Assignee: REATA PHARMACEUTICALS, INC.
C07C255/47C07D231/54C07D239/70C07D401/04C07D403/04C07D413/04C07D417/04C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,814,338
App. No.
17/457,808
Granted
Nov 14, 2023
Kind
B2
Abstract

Disclosed herein are novel antioxidant inflammation modulators, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds and compositions thereof are also provided.

Claims (48)

1. A compound of the formula:

wherein:

n is 1 or 2;

R 1 and R 2 are each independently hydrogen, alkyl (C≤12) , aryl (C≤12) , or aralkyl (C≤12) ;

or

R 1 and R 2 are taken together and are alkanediyl (C≤12) ;

R 3 is absent, hydrogen, alkyl (C≤12) , or aryl (C≤12) ;

R 5 is absent, hydrogen, alkyl (C≤12) , substituted alkyl (C≤12) , or aryl (C≤12) ; and

R 6 is hydrogen, amino, halo, cyano, or oxo; or

alkyl (C≤12) , —C≡C-trimethylsilyl, aryl (C≤12) , aralkyl (C≤12) , heteroaryl (C≤12) , acyl (C≤12) , alkoxy (C≤12) , amido (C≤2) , or a substituted version of any of these groups; or

or a salt or tautomer thereof.

2. The compound of claim 1 , wherein n is 1.

3. The compound of claim 1 , wherein n is 2.

4. The compound according to any one of claims 1 - 3 , wherein R 1 or R 2 is hydrogen.

5. The compound of claim 4 , wherein R 1 and R 2 are each hydrogen.

6. The compound of claim 4 , wherein R 1 is alkyl (C≤12) and R 2 is hydrogen.

7. The compound of claim 6 , wherein R 1 is methyl or ethyl.

8. The compound of claim 4 , wherein R 1 is aryl (C≤12) or aralkyl (C≤12) and R 2 is hydrogen.

9. The compound of claim 8 , wherein R 1 is phenyl or benzyl.

10. The compound according to any one of claims 1 - 3 , wherein R 1 and R 2 are alkyl (C≤12) .

11. The compound of claim 10 , wherein R 1 and R 2 are each methyl.

12. The compound according to any one of claims 1 - 3 , wherein R 1 and R 2 are aralkyl (C≤12) .

13. The compound of claim 12 , wherein R 1 and R 2 are each benzyl.

14. The compound according to any one of claims 1 - 3 , wherein R 1 and R 2 are taken together and are alkanediyl (C≤12) .

15. The compound according to any one of claims 1 - 3 , wherein R 3 is absent.

16. The compound according to any one of claims 1 - 3 wherein R 5 is alkyl (C≤12) or substituted alkyl (C≤12) .

17. The compound of claim 16 wherein R 5 is methyl, tert-butyl, cyclohexyl, trifluoromethyl or 1-hydroxyeth-2-yl.

18. The compound according to any one of claims 1 - 3 , wherein R 5 is aryl (C≤12) .

19. The compound of claim 18 , wherein R 5 is phenyl.

20. The compound according to any one of claims 1 - 3 , wherein R 6 is hydrogen, amino, halo, cyano, or oxo.

21. The compound of claim 20 wherein R 6 is hydrogen.

22. The compound of claim 20 , wherein R 6 is amino.

23. The compound of claim 20 , wherein R 6 is halo.

24. The compound of claim 23 , wherein R 6 is bromo or chloro.

25. The compound of claim 20 , wherein R 6 is cyano.

26. The compound according to any one of claims 1 - 3 , wherein R 6 is alkyl (C≤12) .

27. The compound according to any one of claims 1 - 3 , wherein R 6 is aryl (C≤12) or substituted aryl (C≤12) .

28. The compound of claim 27 , wherein R 6 is phenyl, 2-methylphenyl, 3-methylphenyl, or 4-methylphenyl or 3-chlorophenyl, 4-chlorophenyl, 2-chlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-methoxyphenyl, 3-methoxyphenyl, or 4-methoxyphenyl.

29. The compound according to any one of claims 1 - 3 , wherein R 6 is heteroaryl (C≤12) .

30. The compound of claim 29 , wherein R 6 is 3-pyridyl, 4-pyridyl, 2-methyl-2H-tetrazol-5-yl, 2-benzyl-2H-tetrazol-5-yl, 5-methyl-1,2,4-oxadiazol-3-yl, 5-methyl-1,3,4-oxadiazol-2-yl, 3-methyl-1,2,4-oxadiazol-5-yl, 1-methyl-1H-1,2,4-triazol-3-yl, 1-methyl-1H-pyrazol-4-yl, 2-pyridyl, or 1-isopropyl-1H-1,2,4-triazol-3-yl.

31. The compound according to any one of claims 1 - 3 , wherein R 6 is amido (C≤12) .

32. The compound according to any one of claims 1 - 3 , wherein R 6 is acyl (C≤12) or substituted acyl (C≤12) .

33. The compound according to any one of claims 1 - 3 , wherein R 6 is alkoxy (C≤12) .

34. The compound of claim 33 wherein R 6 is methoxy.

35. The compound of claim 32 , wherein R 6 is substituted acyl (C≤12) .

36. The compound of claim 35 , wherein R 6 is —C(O)-methoxy or —C(O)-ethoxy.

37. The compound of claim 1 , wherein the compound is further defined as:

or a salt or a tautomer thereof.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0228 →
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0130 →
AMENDED AND RESTATED PATENT SECURITY AGREEMENT Recorded Jul 12, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064264/0557 →
PATENT SECURITY AGREEMENT Recorded May 18, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063697/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2021
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 058315/0551 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2021
From: AAPHARMASYN LLC
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 058315/0819 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2021
From: BOLTON, GARY L.; CAPRATHE, BRADLEY; LEE, CHITASE; ROARK, WILLIAM H.
To: AAPHARMASYN L.L.C
Reel/Frame 058315/0650 →
Continuity (7)
Continuation 16701585 · Dec 3, 2019
Continuation 15861758 · Jan 4, 2018
Continuation 14877974 · Oct 8, 2015
Continuation 13939818 · Jul 11, 2013
Continuation 13330378 · Dec 19, 2011
Provisional Application 61424601 · Dec 17, 2010
Related Publication 20220281807A1 · Sep 8, 2022